COL1A1 and systemic sclerosis: Recent data highlight that immune complexes may induce ECM remodeling changes in FB through endothelial damage and that commercial ATA polyclonal IgG induces overexpression of ACTA2 and COL1A1 in FB from SSc (5, 6).